Clinic
Clearchoicemd, PLLC
Clearchoicemd, PLLC was paid $10.84M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoCLEARCHOICEMD, PLLC
BERLIN, VT 05641
BERLIN, VT 05641
33aNPI1851722417assigned 12/09/2013
33bProvider typeUrgent Care Clinic/Center
28Total paid$10.84M
24GClaims230,305
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Vermont
Rank by total paid#1 of 5
Median peer was paid$748K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HAMPERS, MARCUS controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,382 | $1.17M | |
| 2019 | 15,459 | $1.03M | |
| 2020 | 16,354 | $931K | |
| 2021 | 33,152 | $1.74M | |
| 2022 | 52,478 | $1.94M | |
| 2023 | 48,037 | $1.92M | |
| 2024incomplete | 44,443 | $2.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 66,854 | 58,536 | $4.57M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15% | 20,476 | 18,146 | $1.66M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 33,647 | 29,376 | $1.57M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 21,541 | 19,285 | $1.27M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.6% | 24,288 | 21,057 | $820K |
| 87428 | 3.0% | 6,528 | 5,823 | $328K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 20,523 | 8,538 | $211K |
| 87430 | <1% | 10,746 | 9,256 | $107K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 671 | 568 | $49K |
| 87400 | <1% | 4,776 | 2,239 | $38K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,172 | 2,878 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 925 | 831 | $32K |
48 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 445 | $26K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 428 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 721 | $13K |
| 87420 | <1% | 1,541 | $11K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 228 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 211 | $6K |
| 81025 | <1% | 1,025 | $5K | |
| 73610 | <1% | 355 | $5K | |
| 81003 | <1% | 3,354 | $5K | |
| 80305 | <1% | 558 | $5K | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 129 | $4K |
| 73630 | <1% | 304 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 366 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 275 | $3K |
| 90756 | <1% | 169 | $2K | |
| 73110 | <1% | 149 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 284 | $2K |
| 93000 | <1% | 123 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 34 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $1K |
| 86308 | <1% | 219 | $970.82 | |
| A4570 | Splint | <1% | 26 | $855.83 |
| 90674 | <1% | 58 | $827.06 | |
| 99205 | Prolong outpt/office vis | <1% | 14 | $601.96 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 521 | $556.27 |
| 73130 | <1% | 42 | $477.95 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 337 | $453.56 |
| 73140 | <1% | 63 | $433.92 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 33 | $390.92 |
| A9150 | Non-prescription drugs | <1% | 275 | $362.50 |
| 29515 | <1% | 15 | $247.31 | |
| 73562 | <1% | 15 | $223.30 | |
| 29125 | <1% | 12 | $220.11 | |
| A4565 | Slings | <1% | 13 | $159.48 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 30 | $142.65 |
| 36415 | Collection of venous blood by venipuncture | <1% | 306 | $129.00 |
| 69210 | <1% | 12 | $108.38 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 84 | $88.80 |
| S9083 | Global fee urgent care centers | <1% | 32 | $48.75 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 103 | $34.03 |
| 82962 | <1% | 14 | $30.66 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 46 | $14.69 |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | <1% | 13 | $10.20 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 56 | $7.23 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 66 | $5.40 |
| 87999 | 0% | 1,705 | $0.00 | |
| 99072 | 0% | 16 | $0.00 | |
| TELEH | Telehealth inpt pharm mgmt | 0% | 1,320 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMPERS, MARCUS (CHIEF EXECUTIVE OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.